HB
Therapeutic Areas
Bonesupport Pipeline
| Drug | Indication | Phase |
|---|---|---|
| CERAMENT G | Infection prevention in open fractures (Inpatient) | Commercial |
| CERAMENT BONE VOID FILLER | Non-infected bone voids | Commercial |
| CERAMENT V | Bone infection (Vancomycin-sensitive) | Commercial (ex-U.S.) |
| CERTiFy Clinical Trial | Clinical evidence generation | Post-Market Study |
Leadership Team at Bonesupport
TS
Torbjörn Sköld
Chief Executive Officer
HJ
Håkan Johansson
Chief Financial Officer
AA
Annelie Aava Vikner
EVP Global Marketing
MD
Michael Diefenbeck
EVP Medical & Clinical Affairs, Chief Medical Officer
FM
Fergus MacLeod
GM & EVP Commercial Operations EUROW
LJ
Lennart Johansson
Chairman of the Board
MI
Mary I O’Connor
Board Member
BO
Björn Odlander
Board Member
CR
Christine Rankin
Board Member
JV
Jens Viebke
Board Member